You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 19, November 19, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Journalology/ Peer Review/ Authorship
 •Medical Practice
 •Medical Ethics
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Registering Clinical Trials

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Drs Dickersin and Rennie1 called for comprehensive registration of all randomized clinical trials. They argued that such a repository would allow reciprocal transfer of knowledge between the institutions conducting the trials and the community that actively participates in the trials or has an interest in the study outcomes. It would be a matter of open record as to which studies were not yet published. Trials that are completed, but yet unpublished, could still be included in literature reviews. This would ensure a more rigorous appraisal of all the information available on a treatment.

Novartis recognises the need to share clinical trial results in an appropriate and timely manner. We have developed a policy on the communication and publication of clinical trial results that is in line with various guidelines including the Pharmaceutical Research and Manufacturers of America (PhRMA) principles on the conduct and communication of clinical trial . . . [Full Text of this Article]

Giovanni Della Cioppa, MD
Clinical Research and Development
Novartis Horsham Research Centre
Horsham, West Sussex, England

Jean-Jacques Garaud, MD
Clinical Research and Development
Novartis Pharmaceuticals Corporation
East Hanover, NJ
On behalf of the Pharmaceuticals Division of the Novartis Group



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Registering Clinical Trials
Ira Leviton
JAMA. 2003;290(19):2545.
EXTRACT | FULL TEXT  

Registering Clinical Trials—Reply
Kay Dickersin and Drummond Rennie
JAMA. 2003;290(19):2546.
EXTRACT | FULL TEXT  

Registering Clinical Trials
Kay Dickersin and Drummond Rennie
JAMA. 2003;290(4):516-523.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.